RepliCel Life Sciences
BC - VancouverBiotechnology
Focus: RepliCel Life Sciences is a Vancouver-based biotechnology company focused on autologous cell therapies for dermatological and musculoskeletal healing applications. The company is pre-revenue and operates at early clinical stages with a niche focus on regenerative medicine.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About RepliCel Life Sciences
AI assessmentNot HiringNo open roles listed right now. Follow RepliCel Life Sciences to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Long-Term Follow-up of the Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic A
TendinosisClinical Trials (1)
NCT02655042Long-Term Follow-up of the Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis
N/AHelp build intelligence for RepliCel Life Sciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.